BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
Elara Capital Recommends 'Buy' On Sanofi India
According to Elara Capital, strong operating performance by Sanofi India in January-March quarter reinforces its positive view. Exports are likely to recover on the back of currency tailwinds and higher volume, the brokerage adds.